SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004014
Filing Date
2024-02-15
Accepted
2024-02-15 20:48:40
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02162024_010234.html 4  
1 form4-02162024_010234.xml 4 4142
  Complete submission text file 0001415889-24-004014.txt   5620
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMUNIX PHARMACEUTICALS, INC. 2 TOWER PLACE, #1100 SOUTH SAN FRANCISCO CA 94080
Business Address
Derynck Mika K (Reporting) CIK: 0001865125 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 24645560